期刊文献+

第二眼超声诊断乳头状甲状腺癌^(131)I治疗后颈部SPECT/CT异常摄碘灶性质 被引量:1

Second-eye ultrasound in diagnosis of the iodine uptake lesions in SPECT/CT in thyroid cancer patients after ^(131)I treatment
下载PDF
导出
摘要 目的探讨第二眼超声诊断乳头状甲状腺癌131I治疗后颈部SPECT/CT显像中异常摄碘灶性质的价值。方法对41例颈部SPECT/CT中见异常摄碘灶的131I治疗后乳头状甲状腺癌患者行SPECT/CT引导下第二眼超声扫查,判断其良恶性,根据细针穿刺细胞学检查(FNAC)或随访结果进行确诊。结果对11例行FNAC:7例确诊为淋巴结转移,第二眼超声诊断其中6例为淋巴结转移、1例为良性,4例FNAC确诊为良性,第二眼超声均诊断为良性。对30例持续随访:8例第二眼超声诊断为正常淋巴结,其中6例随访诊断为良性,2例随访诊断为淋巴结转移;7例第二眼超声诊断为转移淋巴结,其中3例随访诊断为良性,4例随访诊断为复发或转移;15例第二眼超声未见病灶,随访诊断为良性。结论SPECT/CT引导下第二眼超声可提高诊断甲状腺癌131I治疗后淋巴结转移或复发的准确率。 Objective To evaluate the value of the second-eye ultrasonography in diagnosis of the iodine uptake lesions in SPECT/CT in patients with thyroid carcinoma after ^131 I treatment.Methods Totally 41 thyroid carcinoma patients after ^131 I treatment with iodine uptake lesions in the neck in SPECT/CT underwent SPECT/CT guided second-eye ultrasound to diagnose the benign and malignant of the lesions.The nature of the lesions were confirmed by fine needle aspiration cytology(FNAC)and follow-up.Results There were 11 receiving FNAC.Among them,7were diagnosed as metastatic lymph nodes in which 6were diagnosed as metastatic lymph nodes 1was diagnosed as benign lesions by second-eye ultrasound,4were diagnosed as benign lesions which were all diagnosed by second-eye ultrasound correctly.There were 30 being seen for follow-up,among them 8were shown as normal lymph node by second-eye ultrasound in which 6were diagnosed as benign and 2were diagnosed as metastasis or recurrence during follow-up,7were shown as metastasis in which 3were diagnosed as benign and 4were diagnosed as metastasis or recurrence during follow-up,15 showed no lesions which were diagnosed as benign during follow-up.Conclusion SPECT/CT guided second-eye ultrasound can improve the diagnostic accuracy of metastatic or recurrence in thyroid carcinoma after ^131 I treatment.
出处 《中国介入影像与治疗学》 CSCD 2014年第12期792-795,共4页 Chinese Journal of Interventional Imaging and Therapy
关键词 甲状腺癌 乳头状 淋巴转移 超声检查 体层摄影术 发射型计算机 单光子 Thyroid cancer papillary Lymphatic metastasis Ultrasonography Tomography emission-computed sin-gle-photon
  • 相关文献

参考文献15

  • 1Sherman SI. Thyroid carcinoma. Lancet. 2003, 361 (9356) : 501- 511.
  • 2川玲,赵文锐,朱家瑞,许根祥,王新强,高春华,方庭正.分化型甲状腺癌^(131)I治疗后SPECT/CT融合显像的临床研究[J].中国医学影像技术,2006,22(9):1412-1414. 被引量:14
  • 3Xue YL, Qiu ZL, Song HJ, et al. Value of lalI SPECT/CT for the evaluation of differentiated thyroid cancer: A systematic re- view of the literature. Eur J Nucl Med Mol Imaging, 2013, 40 (5) :768-778.
  • 4Wakabayashi H, Nakajima K, Fukuoka M, et al. Double-phase (131)I whole body scan and 1311 SPECT-CT images in patientswith differentiated thyroid cancer: Their effectiveness for accurate identification. Ann Nucl Med, 2011,25(9):609-615.
  • 5Rosdrio PW, De Faria S, Bicalho L, et ah Uhrasonographic dif- ferentiation between metastatic and benign lymph nodes in pa- tients with papillary thyroid carcinoma. J Ultrasound Med, 2005, 24(10) : 1385-1389.
  • 6Kim DW, Choo H J, Lee YJ, et ah Sonographic features of cervi cal lymph nodes after thyroidectomy for papillary thyroid carcino- ma. J Ultrasound Med, 2013,32(7) :1173-1180.
  • 7Gritzmann N, Hollerweger A, Macheiner P, et ah Sonography of soft tissue masses of the neck. J Clin Ultrasound, 2002, 30(6) : 356-373.
  • 8潘莉莉,李云川,孙书怡.甲状腺癌术后复发结节与炎性肉芽肿超声对比[J].中国老年学杂志,2013,33(14):3425-3426. 被引量:2
  • 9Kloos RT, Mazzaferri EL. A single recombinant human thyrotro- pin stimulated serum thyroglobulin measurement predicts differ- entiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab, 2005,90:5047- 5057.
  • 10Rajkovaca Z, Kovacevi P, Staneti M, et al. Assessment of re- combinant human thyrotropin application in following-up pa- tients with well-differentiated thyroid carcinoma. Vojnosanit Pregl, 2012,69(11) : 941-946.

二级参考文献15

  • 1Mazzaferri EL, Robbins R J, Spencer CA, et al. A consensus report of the role of serum thyroglobublin as a monitoring method for low-risk patientswithpapillarythyroidcarcinoma [J]. JClinEndocrinol Meta, 2003, 88(4): 1433-1441.
  • 2Pacini F, Fugazzola L, Lippi F, et al. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer [J]. J Clin Endocrinol Metab, 1992, 74(6): 1401-1404.
  • 3Spencer CA, Wang C, Fatemi S, et al. Serum thyroglobulin autoanti bodies: Prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma[J]. J Clin Endocrinol Metab, 1998, 83(4): 1121
  • 4Massart C, Maugendre D. Importance of the detection method for thyroglobulin antibodies for the validity of thyroglobulin measurements in sera from patients with Graves' disease[J]. Clin Chem, 2002,48(1): 102-107.
  • 5Girelli ME, De Vido D. Serum thyroglobulin measurements in differentiated thyroid cancer[J]. Biomed Pharmacother, 2000, 54(6): 330-333.
  • 6Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyroglobulin assays[J]. Clin Chem, 1996, 42(1): 164-173.
  • 7Hjiyiannakis P, Mundy J, Harmer C. Thyroglobulin antibodies in differentiated thyroid cancer[J]. Clin Oncol, 1999, 11(4): 240-244.
  • 8Yuka Y,Yoshihiro N,Toshihide M,et al.Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma[J].J Nucl Med,2003,44(12):1905-1910.
  • 9Cholewinski SP,Yoo KS,Klieger PS,et al.Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I[J].J Nucl Med,2000,41(7):1198-1202.
  • 10Beyer T,Townsend DW,Brun T,et al.A combined PET/CT scanner for clinical oncology[J].J Nucl Med,2000,41(8):1369-1379.

共引文献26

同被引文献7

引证文献1

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部